Early phase development solutions: Accelerating answers for a global pandemic
3 October 2024
Break through with urgency
Our rapid response to the COVID-19 pandemic helped a sponsor reduce their IND program from 12 to 5 months. Working with Labcorp for Phase I and II trial work support, the sponsor achieved FDA emergency use authorization in just over a year.
Discover more benefits of early phase development solutions
White paper
Find out how Labcorp’s programmatic approach can save 30% on your IND program.
Info sheet
Make every day of your journey count with early phase development solutions.
Early phase development solutions
Advance your compound more quickly through critical milestones with our experienced team.
Vaccines
Leverage a comprehensive suite of discovery in vivo and in vitro services.